An evolving landscape: Management updates in EGFR-mutant NSCLC from November 2023
Agenda
General Information
The panel of world-leading experts explore the recent updates and developments in the diagnosis, treatment, and management of lung cancer with a specific focus on the translation of new data into clinical practice.
Learning objective:
After participating in this webinar, viewers should be able to:
• Review the latest advances for EGFR mutations in NSCLC.
• Discuss how the data may impact the management of patients with
EGFR-mutant NSCLC in clinical practice.
Faculty:
- Matthew Krebs (UK)
- Antonio Passaro (Italy)
- Rosario García Campelo (Spain)
- Rafaelle Califano (UK)
- Alexander Spira (US)
Claim your CPD credits
The content of the following has been certified by the CPD Certification Service as conforming to continuing professional development principles.
You can claim 1.0 credits for this activity.
Please make a note of the below information to claim your points.
Name of activity: Janssen Oncology Medical Education Webinar (OME) Post ESMO: An evolving landscape: Management updates in EGFR-mutant NSCLC from November 2023.
Certificate number: 50217
Date of activity: November 2023
CPD Provider: Sciterion 013096
